Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Liver Tumor, Metastatic Liver”

233 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 233 results

Not applicableStudy completedNCT00724503
What this trial is testing

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaLiver Metastases
Sirtex Medical 530
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT02181075
What this trial is testing

Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours

Who this might be right for
Liver Tumour
University of Oxford 10
Not applicableStudy completedNCT00482586
What this trial is testing

Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy

Who this might be right for
Liver CancerMetastatic Cancer
Vanderbilt University 137
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Not applicableStudy completedNCT03741088
What this trial is testing

Study to Evaluate VORTX Rx (Theresa)

Who this might be right for
Carcinoma, HepatocellularLiver Metastases
HistoSonics, Inc. 8
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Not applicableLooking for participantsNCT06787625
What this trial is testing

Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases

Who this might be right for
Colo-rectal Cancer
Regina Elena Cancer Institute 10
Not applicableActive Not RecruitingNCT03408665
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer

Who this might be right for
Liver CancerLiver Metastases
Centre Oscar Lambret 280
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Looking for participantsNCT03895359
What this trial is testing

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

Who this might be right for
Hepatocellular Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 128
Not applicableEnded earlyNCT00264979
What this trial is testing

Evaluation of 2 Resection Strategies of Synchronous Colorectal Cancer Metastases

Who this might be right for
Colorectal CancerHepatic Metastases
Rennes University Hospital 105
Testing effectiveness (Phase 2)Study completedNCT00511862
What this trial is testing

TheraSphere for the Treatment of Liver Metastases

Who this might be right for
Colorectal CancerCarcinoma, NeuroendocrineNeoplasm Metastasis
Boston Scientific Corporation 151
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Not applicableUnknownNCT04682847
What this trial is testing

Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers

Who this might be right for
Liver NeoplasmsHepatic CirrhosisHepatic Carcinoma+6 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 40
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT02305459
What this trial is testing

CIRSE Registry for SIR-Spheres Therapy

Who this might be right for
Liver Carcinoma
Cardiovascular and Interventional Radiological Society of Europe 1,051
Testing effectiveness (Phase 2)Study completedNCT01005199
What this trial is testing

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Swiss Cancer Institute 106
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Load More Results